U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

  1. Home
  2. Drugs
  3. News & Events for Human Drugs
  4. Webinar: Learn About ClinicalTrials.gov Modernization and How to Provide Input - 03/06/2020
  1. News & Events for Human Drugs

Webcast | Virtual

Event Title
Webinar: Learn About ClinicalTrials.gov Modernization and How to Provide Input
March 6, 2020


Date:
March 6, 2020
Time:
1:00 p.m. - 2:00 p.m. ET

Download Slides

The National Library of Medicine (NLM) issued a Request for Information (RFI) to obtain stakeholder feedback on modernizing ClinicalTrials.gov.

NLM is asking for your input on how to deliver an improved user experience on an updated platform that will accommodate growth and enhance efficiency. Creating a roadmap for modernization requires feedback from a wide array of stakeholders including sponsors and investigators who submit clinical trial information to the site on how to continue serving, balancing, and prioritizing their information needs.

We’re asking for your input on how it can best continue to serve your needs for many more years to come. This presentation will describe our effort and the recently issued Request for Information (RFI) to obtain your input.

TOPICS COVERED

INTENDED AUDIENCE

  • Study sponsors and investigators who use the Web-based submission system called the Protocol Registration and Results System (PRS) to ensure that their clinical studies are registered and have results reported on ClinicalTrials.gov.
  • Researchers using ClinicalTrials.gov information to inform their work or to improve the clinical research enterprise (example, perform landscape analysis to understand what research has been completed or where gaps in research exist).  
  • Clinical research coordinators who need to understand what information needs to be collected or reported to ClinicalTrials.gov.

LEARNING OBJECTIVES

  • Learn about the ClinicalTrials.gov modernization effort
  • Understand how to submit comments that could shape enhancements to ClinicalTrials.gov
  • List the three relevant topic areas where NLM is seeking input.

SPEAKER

Rebecca Williams, PharmD, MPH
Acting Director
ClinicalTrials.gov | National Library of Medicine | NIH

RESOURCES

Back to Top

Back to Top